Wellgistics Health, Inc. · NASDAQ:WGRX
Wellgistics Health — Investor Presentation (May 2025)
28 slides from Wellgistics Health's investor presentation, May 15, 2025
Slide 1: Wellgistics Health: Redefining prescription access across America
VN Well istics Health: ‘ Redefining prescription 1 y P we. access across America
Slide 2: Legal Disclaimer: Forward-Looking Statements
Legal Disclaimer Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that reflect current views of the Company with respect to, among other things, operations and financial performanc
Slide 3: Legal Disclaimer: Notice to Investors
Legal Disclaimer Notice to Investors ‘The information set forth in this presentation has been prepared for informational purposes and does not constitute any offer to sell or the solicitation of an offer to buy any of the Company's securities, nor will there be any sales of the Company's securities
Slide 4: Transforming the pharmaceutical fulfillment network without owning bricks and mortar
Transforming the pharmaceutical fulfillment network without owning bricks and mortar. co} <s Healthcare technology Vertically-integrated: Bringing pharmaceutical services to Ecosystem seamlessly connects redefine prescription access across manufacturers, pharmacies, ‘America providers, employers and
Slide 5: Centralized Intelligence with Best-in-Class Services
Centralized Intelligence with Best-in-Class Services w = 4 & Services Bey > a doo 7 “ ee © Data > aa Pharma Manufacturer Provider v Wellgi 1G Services v On 4 wo pw e ‘ Pees ue & bata > vo fay : : SS = a Independent Pharmacy Be y Network Patient Payor / PBM
Slide 6: Pharmaceutical costs spiraling out of control
w Pharmaceutical costs spiraling out of control +15% per annum 99% of employers believe drug prices are a significant threat to healthcare affordability. ¢§ The market is broken. —EEE—.._
Slide 7: 82% of adults
82% of adults believe the cost of prescription drugs is unreasonable 3 out of 10 adults skip treatments because their drugs cost too much Patients have had enough. ESS
Slide 8: Multi-Billion Dollar Market for Drug Pricing Transparency
Multi-Billion Dollar Market for Drug Pricing Transparency Ga ~$1.1T US Pharmaceutical market size, 2033P a ~$81B Annual drug spend by self-funded employers, covering 154M+ patient lives Sources: Magnetaba; Precedenceresearch; KFE: Management analysis; Dug Channels; Barrons; $16.9B+ Estimated Al-driv
Slide 9: We're changing the paradigm
We’re changing the paradigm: From the Manufacturer’s door to the Patient’s hands Wellgistics Distribution <7 a0 > te. aes, es Manufacturer Distribution ) Employers see a significant reduction in pharmaceutical costs > Wellgistics Tech & Hub™ 8 pee (4) Provider Vv Wellgistics Pharmacy” oD, iiza=) Pha
Slide 10: Vertically Integrated, Tech-Driven Pharmacy Ecosystem
Vertically Integrated, Tech-Driven Pharmacy Ecosystem *W@ Distribution Wholesale Distributor +3PL+Cold Chain NABP Accredited in all 50 States 125+ Manufacturers 6,000+ Independent Pharmacies (30%+ Market Share & Growing) Sources: Cardinal Health WY’ Wellgistics = Tech & Hub™ Digital Pharmacy and Hub
Slide 11: Monetization across the entire Value Chain
Monetization across the entire Value Chain w ri Pharmacy 5 pes Wholesaling Vv Proprietary i EinsteinAl allows a G3 Rea &D us to uncover Einsteinal cS ee eeitnal opportunities \ bd } using pharmacy af. e*" Network KPIs & 5 ©,c%% Pharmacy Model point-of-sale Vv data. + a Employer Subscription Model
Slide 12: Acquisition of Peek Meds
Acquisition of Peek Meds: Peek Meds Marketplace provides patients personalized, comparison pricing in one place: e fas a One of the ;/;- eres Eliquis. Rx shopping coco, "ovcs loos $0 Highlights pharma copay offset S programs to promote added savings ee marketplaces . . theme GEES Includes patient’s
Slide 13: Vertical integration means we can do what others can't
Vertical integration means we can do what others can’t. Unlike other popular Rx savings programs that only reveal their own pricing, and require a lengthy time to implement... We combine technology, supply chain, and market access expertise to harness the power of savings solutions from manufacturer
Slide 14: Peek Meds Acquisition
Peek Meds Acqu & luis ql eet 25g) ourPok ter ea ‘urpeeredphomecy ace Unlocking & =< penta cent 1 8-23%+ 2mM+ 95% ‘Other cosh options near S431 9 Cn Top-line Claims evaluated in NDCs match cost savings last 6 months Industry-leading partners include: CtyReectoud PARAMOUNT, Costpius <> SingleCare Driv
Slide 15: Wellgistics AI: Leveraging AI to make our process faster
Wellgistics Al: Leveraging Al to make our process w faster, simpler and easier iE les ay © Launched Direct Al integration with 2024 our existing tech stack Improve patient access with key components: @ 6 G rv) -) Al Benefit Al Prior Al Copay Al Customer AlConsent Al Enrollment Verification Authoriza
Slide 16: Unified Tech Platform
Unified Tech Platform OUR FULLY-INTEGRATED ECOSYSTEM CONNECTS EVERY TOUCHPOINT, ENABLING: Seamless Pharmacy Operations Direct Manufacturer Fulfillment A. Patient Savings as, Transparency Better Patient Access Hub Services W’ Wellgistics Wellgistics Al Tech & Hub” Einstein Peek Meds w 6
Slide 17: Wellgistics' sustainable moat through vertical integration
Wellgistics’ sustainable moat through vertical integration w Distribution” Roa ws, * Manufacturer Direct Relationships * 3PL&Cold Chain Capabilities In-house Distribution + Speed Advantage over Incumbents Pharmacy~ Tech & Hub™ = a “ we + 36 State Licenses & + Hub Services panes infouse Expanding ‘ul
Slide 18: Vertically-Integrated Prescription Integration Timeline
Vertically-Integrated Prescription Integration Timeline w 1Q-2Q 2025 3Q-4Q 2025, 2026 Fully integrate Wellgistics Al Build out partnerships Pursuit of strategic transactions Finalize Peek Meds acquisition Roll out Wellgistics Al Streamline tech stack Build out exec team Add market endpoints We plan
Slide 19: Expert leaders in growth execution
Expert leaders in growth execution Brian Norton cEO \W Financial leader with 23+ years of progressive experience in coross border M&A, VC & PE fund, raising Michael Navin Incoming CCO W > Founded Peek Technologies & previously exited EMG to Ogitvy Health ‘Effective upon the closing of Peek Acquisiti
Slide 20: Landmark support for PBM reform at Federal & State level
Landmark support for PBM reform at Federal & State level w Current administration has clearly expressed its support for: W’ Lowering the cost of prescription drugs W Patient costs transparency Fact Sheet: President Donald J. eee eee ocr Trump Announces Actions to W Fair, transparent & open markets v
Slide 21: Wellgistics Health is seeking to:
Wellgistics Health is seeking to: aE ae (8 ooo Comoe) Expand our vertically Accelerate direct-to-manufacturer integrated pharmacy and programs to deliver lower-cost, distribution network higher-access prescriptions 68 Deploy Al-powered technologies like Wellgistics Al and Peek Meds Marketplace at na
Slide 22: The Future We Create
The Future We Create w Imagine a world where... Employers lower prescription drug costs by up to 60%. WwW Patients get instant, real-time access to the best price at their chosen pharmacy. Manufacturers bypass rebate middlemen and reach patients directly — faster and more profitably. im _-_ —» of Te
Slide 23: Wellgistics Health: Prescription Price Transparency
W’ Wellgistics Health” Prescription » PY. Price a a Transparency.
Slide 24: Annex
WY’ Wellgistics Heal Annex
Slide 25: Board of Directors
Board of Directors Suren Ajjarapu Chairman W’ Founder, Chairman, and CEO of TRxADE Health, Inc. (n/k/a Sclenture: Holdings, Inc.) W Entrepreneur with leadership in Pharmaceuticals, Biofuels and Information Technology sectors W_ Education: MS in Environmental Engineering and an MBA specializing in In
Slide 26: Revenue & Margin
Revenue & Margin & SOURCES OF REVENUE Wholesales Distribution Prescription Fulfillment Pharmaceutical Manufacturer Services Prior Authorizations Therapeutic Interchange Recurring revenue: SaaS Transactional Services RecTransfer use of Provider, PMS, Clicks technology Sureseripts Subscription Fees Ne
Slide 27: Wellgistics Health
WY’ Wellgistics Health’ |
Slide 28: Leaders in executing growth strategies
w w Leaders in executing growth strategies Brian Norton CEO Financial leader with 23+ years of progressive experience in cross border M&A, VC & PE fund raising Extensive track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation Has led high-performin
Wellgistics Health — Investor Presentation (May 2025) on 6ix